Equine Immunoglobulin G from Equitech-Bio
LIGHT DIAGNOSTICS™ Calicivirus Genotype 1&2 OligoDetect® from CHEMICON
Secure-Seal hybridization chamber gasket, eight chambers, 9 mm diameter, 0.8 mm deep *set of 20* from Molecular Probes (Invitrogen)
Rabbit Anti-SRC-RSV Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products:(Date:11/6/2009)... 2009) The Monell Center and the Chinese Academy ...rnational Meeting on Taste and Smell Research. Org...e meeting will be the first international meeting ...eshner, Chief Executive Officer, American Associat...ublisher of Science magazine, will open the meetin...
(Date:11/5/2009)...been awarded a training grant in the amount of $2,...ts Integrative Graduation Education and Research T...rant to be awarded to Kent State. The grant, which...tment Act of 2009, runs through 2014. , The gran...nt aquatic resource sensing (EARS). The purpose of...
(Date:11/4/2009)... the cities of Long Beach and Riverside are respon...childhood asthma, and the true impact of air pollu...been underestimated, according to researchers at t...he study, which appears in an online edition of th...hat nine percent of all childhood asthma cases in ...
Breaking Biology News(10 mins):Monell Center joins with CAS to host Beijing meeting on taste and smell research 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USC study finds big air pollution impacts on local communities 2Fifth Third Processing Solutions to Offer mPay Gateways Patient Payment System to Its Health Care Customers 55859 1Fifth Third Processing Solutions to Offer mPay Gateways Patient Payment System to Its Health Care Customers 55859 2Fifth Third Processing Solutions to Offer mPay Gateways Patient Payment System to Its Health Care Customers 55859 3Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 1Mission Pharmacal Acquires Dr Smiths Diaper Ointment 55855 2AccuVein HealthTrust Finalize Group Purchasing Agreement for Vein Illumination Device 55850 1AccuVein HealthTrust Finalize Group Purchasing Agreement for Vein Illumination Device 55850 2...ls shiver when exposed to cold air but not when di...elieve allows the diving seal to conserve oxygen a...ng dives. , The researchers presented the study at...Comparative Physiology 2006: Integrating Diversity...rchers, Arnoldus Schytte Blix, Petter H. Kvadsheim...
...organelle called the nucleolus resides deep within...ost critical functions: it manufactures ribosomes,...nformation carried by messenger RNA into proteins ...Peng, researchers in the Life Sciences Division of...onal Laboratory, have now discovered two pathways ...
...rand new approach to treating severe nerve pain ?b...lar target ?has been discovered by University of U...-dwelling cone snails. , "We found a new way to ...ered by hundreds of millions of people on Earth," ...earch professor of biology, and research director ...
Other Biology News:Seals protect brain, conserve oxygen by turning off shivering response on icy dives 2Seals protect brain, conserve oxygen by turning off shivering response on icy dives 3Regulating the nuclear architecture of the cell 2Regulating the nuclear architecture of the cell 3Regulating the nuclear architecture of the cell 4Regulating the nuclear architecture of the cell 5A new target for painkillers 2A new target for painkillers 3A new target for painkillers 4(Date:11/6/2009)...-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NA...nnounced updated results from a Phase II study of ...metastatic to the lung in a poster presentation at...y Meeting held in Miami Beach, Florida, from Novem..."A Phase II Study of Intravenous REOLYSIN (Wild-ty...
(Date:11/6/2009)...nda for Arrowhead’s 2010 Personalized Medici...lace on February 22-24, 2010 in Philadelphia, has ...ll highlight key issues in forming partnerships an...ces. , Minneapolis, MN (P...’s 2010 Personalized Medicine Partnerships ...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GN... third quarter ended September 30, 2009. GenVec re...) for the three months ended September 30, 2009 co...are) in the comparable quarter of 2008. For the ni...oss was $14.1 million ($0.15 per share), compared ...
(Date:11/5/2009)...RNewswire/ -- DSM Pharmaceutical Products today an...with Galenix, Saint Jean D,Illac, France, where DS...ring partner for Galenix commercial products on a ...te on business development opportunities co-market...he strength of Galenix in drug product development...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3